How do you pronounce RheoDX? A CRM spin-off? Who is in office C1-014?
Rheo Diagnostics is a startup born in 2018 promoted by the Mobile World Capital Barcelona foundation. Its patented technology is born of the collaboration between the UB and the CRM.
Rheo Diagnostics develops a portable in-vitro diagnosis device for the analysis of the elastic properties of red blood cells and detect abnormalities fast (only takes 5 min) and cheaply with a single drop of blood. The test consists of a microfluidic consumable, a reader system and a cloud server where the data is processed and translated into clinical evidence. It is a device with multiple applications in hematology, from diagnosis to monitoring of patients receiving blood transfusions.
With this activity we intend to give an overview of the company and its trajectory; What is the starting point of the project and its link to the CRM; When and which factors made possible the consolidation of RheoDX and what is our day-to-day life in terms of funding, experimental validation and product, and finally which is our letter to the kings for the next years.
|10:15 – 10:25||Welcome by Lluís Alsedà, Director of the CRM|
|10:25 – 10:55||
Tech transfer, from microfluidics theory to a patent.
|10:55 – 11:05||Q&A|
|11:05 – 11:25||
How RheoDX connects entrepreneurial and scientific talent to foster innovation.
|11:25 – 11:35||Q&A|
|11:35 – 12:00||Coffee Break|
|12:00 – 12:20||
Tech transfer, from Laboratory to hospitals.
|12:20 – 12:30||Q&A|
|12:30 – 12:50||
Tech transfer, from technology to a product.
|12:50 – 13:00||Q&A|
|13:00 – 13:15||Closing|